Updating the Infection Risk Reduction Hierarchy: Preventing Transition into Injection

David Vlahov, Crystal M. Fuller, Danielle C. Ompad, Sandro Galea, Don C. Des Jarlais

Research output: Contribution to journalReview articlepeer-review


Current approaches to prevention of blood-borne infections in injection drug users include referral to drug abuse treatment, access to sterile syringes, bleach disinfection of injection equipment, and education about not sharing equipment. However, rates of some blood-borne infections (e.g., hepatitis C virus) remain elevated among injection drug users, especially early after initiation into injection drug use. With lower infection rates in noninjectors and transition into injection drug use occurring most commonly among these noninjectors, prevention of transition into injection drug use as an additional step to reduce risk for acquisition and transmission of blood-borne infections merits closer attention.

Original languageEnglish (US)
Pages (from-to)14-19
Number of pages6
JournalJournal of Urban Health
Issue number1
StatePublished - Mar 2004


  • Hepatitis C virus
  • Hierarchy
  • Human immunodeficiency virus
  • Infection
  • Injection drug use
  • Prevention

ASJC Scopus subject areas

  • Health(social science)
  • Urban Studies
  • Public Health, Environmental and Occupational Health


Dive into the research topics of 'Updating the Infection Risk Reduction Hierarchy: Preventing Transition into Injection'. Together they form a unique fingerprint.

Cite this